Allocations
Cure Ventures, a life sciences venture capital firm focusing on company formation around curative technologies, has closed its inaugural fund, Cure Ventures Fund I, at its targeted hard-cap of $350 million in capital commitments.Â
KKR has held the final close of European Fund VI with $8.0 billion in capital commitments, making it the firm’s largest European Private Equity fund to date, surpassing the $6.6 billion KKR raised for its predecessor vehicle in 2019.Â
Fuel Venture Capital, an early-stage investor in technology and digital companies, will raise money for its next fund using a new funding structure ​its says is positioned​​ to “transform the private markets landscape”.
Institutional investors will be able to ​participate​ in the upcoming Fuel Venture Capital Flagship Fund II, which is aiming to raise $300 million, via The Fuel VC Note, a listed, centrally cleared transferable Note that can be sold and traded throughout its duration.
Investing in the fund in this way enables the potential liquidity and transferability of a stake in an underlying asset class that
The Texas County & District Retirement System (TCDRS) has added two additional private equity funds to its investment portfolio in recent weeks, despite recently announcing a reduction in its annual PE commitment, according to a report by Alternatives Watch.
The new managers hired are growth equity focused Parthenon Capital and ZMC, an investor in media, entertainment, communications and technology business. Parthenon Investors VII, which recently closed at $4.5 billion, received a $110 million commitment, while TCDRS also allocated $75 million to the MC IV fund.
The $42 billion Austin-based pension scheme recently announced it was cutting back its annual commitment
DW Healthcare Partners, a healthcare-focused private equity firm, has closed the DW Healthcare Partners Small Cap, a fund focused on lower middle market healthcare investments, with $210 million in total capital commitments.Â
Schroders Capital, the’ specialist private markets investment division of Schroders, has launched Schroders Capital Climate+ LTAF, a Long-Term Asset Fund, designed to help UK pension fund investors support the net zero transition.
EQT Life Sciences has held the final close of its LSP Dementia Fund, raising approximately €260 million in fee-generating assets under management, meeting the hard cap and surpassing the target fund size of €100 million.
Parthenon Capital, a growth-oriented private equity firm with offices in Boston, San Francisco and Austin, has held the first and final closing of Parthenon Investors VII with more than $4.5 billion in commitments, significantly in excess of its initial $3.5 billion target.
SR One, a transatlantic life sciences investment firm, has closed its second fund at over $600 million, substantially exceeding its target of $500 million. Fund II is the second fund since SR One spun out from GlaxoSmithKline in 2020 to form a fully independent investment firm.Â
Armen, an investment firm focused on acquiring stakes in private equity firms, has held the first close of Armen GP Stakes Fund I at €150 million in capital commitments, and secured a strategic minority investment from a group of French family offices
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
